نتائج البحث

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

• Source: A Phase 1b/2 Study of Docetaxel and Prednisone, With or Without ISIS 183750 (an eIF4E Inhibitor), in Patients With Castrate-Resistant Prostate Cancer

تفاصيل العنوان

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel (NSCLC)

• Source: A Phase 1b/2 Study of Carboplatin-Paclitaxel, With or Without ISIS 183750 (an eIF4E Inhibitor), in Patients With Stage IV Non-Small Cell Lung Cancer

تفاصيل العنوان

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

• Source: The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR.

تفاصيل العنوان

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

• Authors : National Cancer Institute (NCI); EFFECTOR Therapeutics, Inc.

• Source: Phase 1 Dose Escalation Study of Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

تفاصيل العنوان

A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia (Borden-001)

• Authors : The Leukemia and Lymphoma Society; Sarit Assouline, Associate Professor, Department of Oncology, McGill University

• Source: A Phase II Study of Ribavirin in Refractory of Relapsed Acute Myelocytic Leukemia M4 and M5 SubtypesTopisirovic I, Guzman ML, McConnell MJ, Licht JD, Culjkovic B, Neering SJ, Jordan CT, Borden

تفاصيل العنوان

Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients (AML)

• Authors : Jane Liesveld, Principal INvestigator

• Source: A Phase I/II Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML PatientsLiesveld JL, Baran A, Azadniv M, Misch H, Nedrow K, Becker M, Loh KP, O'Dwyer KM,

تفاصيل العنوان

Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia

• Authors : The Leukemia and Lymphoma Society; Sarit Assouline, Principal Investigator

• Source: A Phase I/II Study of Ribavirin and Low-dose Cytarabine Arabinoside (Ara-C) in Acute Myeloid Leukemia (AML) M4 and M5 Subtypes, and AML With High eIF4E Expression

تفاصيل العنوان

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

• Authors : Tim Greten, M.D., Principal Investigator

• Source: A Phase I/II Study of ISIS 183750 in Combination With Irinotecan in Irinotecan-refractory Colorectal CancerDuffy AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, Fioravanti S, Walker M, Abdullah

تفاصيل العنوان

Treatment With Ribavirin for Patients With Metastatic Breast Cancer

• Authors : Wilson Miller, Principal Investigator

• Source: A Phase I/II Exploratory Study of Ribavirin in Metastatic Breast Cancer Expressing Elevated eIF4EKentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KL.

تفاصيل العنوان

Involvement of the Translation Initiation Factors in Resolution of Inflammation in the Elderly Population

• Source: The Involvement of the Translation Initiation Factors eIF4E and eIF4G in Resolution of Inflammation in the Elderly Population

تفاصيل العنوان